STEPHEN BAKER: Open Payments
NPI 1235247180 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 45 payments from 9 companies in 2025. Trend: 2023 $36 · 2024 $71 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $238 |
| Janssen Pharmaceuticals, Inc | 9 | $213 |
| Vanda Pharmaceuticals Inc. | 9 | $178 |
| Alkermes, Inc. | 4 | $106 |
| Teva Pharmaceuticals USA, Inc. | 5 | $97 |
| Neurocrine BioSciences, Inc. | 3 | $80 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
Products named: FANAPT, INVEGA SUSTENNA, REXULTI, ABILIFY ASIMTUFII, ARISTADA, AUSTEDO XR, INGREZZA, SPRAVATO.
Industry payments across PA — which companies pay providers there.
